Sacituzumab Tirumotecan Combined With Immunotherapy in Advanced Thyroid Cancer
Abroad (travel likely)Recruiting
Conditions
Advanced Thyroid Carcinoma · Radioiodine-refractory Differentiated Thyroid Cancer · Poorly Differentiated Thyroid Carcinoma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang, China
Study leads
Minghua Ge
Principal Investigator
Zhejiang Provincial People's Hospital